Oakdale Ear Nose & Throat Clinic is categorized under Blood Related Health Services in Osseo, MN .
Oakdale Ear Nose & Throat Clinic was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Blood Related Health Services business, which does work in the B2C market, and is classified as a Blood Related Health Services, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 9825 Hospital Drive # 203, Osseo, Minnesota MN 55369 or by phoning (763) 416-0618. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Oakdale Ear Nose & Throat Clinic |
| Address: | 9825 Hospital Drive # 203, Osseo, Minnesota 55369 |
| Phone Number: | (763) 416-0618 |
| Website Address: | oakdaleent.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Blood Related Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 6211110 |
| Share This Business: |
Oakdale Ear Nose & Throat Clinic was started in 0 to provide professional Blood Related Health Services under the SIC code 8099 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact for inquiries that concern Oakdale Ear Nose & Throat Clinic by calling the company number (763) 416-0618, as your correspondence is most welcome. Additionally, the physical location of the single location of Oakdale Ear Nose & Throat Clinic can be found at the coordinates 45.1332,-93.47941 as well as the street address 9825 Hospital Drive # 203 in Osseo, Minnesota 55369.
For its online presence, you may visit Oakdale Ear Nose & Throat Clinic’s website at oakdaleent.com and engage with its social media outlets through on Twitter and on Facebook.